Menu Menu

REGN    Regeneron Pharmaceuticals Inc    872589    
Income Statement
Revenue regn-20240930 3,720,700,000
Net Income regn-20240930 1,340,600,000
Profit Margin 36.03%

Balance Sheet
Current Assets 19,333,600,000
Assets 37,441,900,000
Current Liabilities 3,661,000,000
Liabilities 8,116,000,000
Equity 29,325,900,000
Shares Out 108,417,000

Cash Flow Statement
Operating Cash Flow 3,157,700,000
Investing Cash Flow -2,818,700,000

Market Analysis
Market Cap 125,407,729,905
Price 681.58
BVPS 270.49
PB 2.52
EPS 37.77
PE 30.12
PS 8.43
FCF 339,000,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/02 11.86
Apr May Jun
5/02 9.55
Jul Aug Sep
8/01 11.56
Oct Nov Dec
10/31 12.40

Find a discrepancy? The most accurate way to find company fundamental data is to view REGN documents filed with the SEC.


REGN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas